Lurasidone as a potential therapy for bipolar disorder
Young Sup Woo, Hee Ryung Wang, Won-Myong Bahk Department of Psychiatry, Yeouido St Mary's Hospital, The Catholic University of Korea, Seoul, Korea Abstract: Lurasidone is a benzisothiazol derivative and an atypical antipsychotic approved by the US Food and Drug Administration for the acute t...
Enregistré dans:
Auteurs principaux: | Woo YS, Wang HR, Bahk WM |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/bc7a54e3b15f4ed8993d5ea38d81b303 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Lurasidone for the treatment of bipolar depression: an evidence-based review
par: Franklin R, et autres
Publié: (2015) -
Predictors of premature discontinuation of outpatient treatment after discharge of patients with posttraumatic stress disorder
par: Wang HR, et autres
Publié: (2015) -
Korean Medication Algorithm for Bipolar Disorder 2014: comparisons with other treatment guidelines
par: Jeong JH, et autres
Publié: (2015) -
Korean Medication Algorithm Project for Bipolar Disorder: third revision
par: Woo YS, et autres
Publié: (2015) -
Prevalence of bipolar spectrum disorder in Korean college students according to the K-MDQ
par: Bae SO, et autres
Publié: (2013)